Thermo Fisher Scientific’s Clinical Research Business Receives “Best CRO” Recognition at Vaccine Industry Excellence Awards
WILMINGTON, N.C. (April 23, 2025) – The PPD™ clinical research business of Thermo Fisher Scientific received the “Best CRO” Award at the 18th annual Vaccine Industry Excellence (ViE) Awards during the 2025 World Vaccine Congress, recognizing its success in helping customers develop safe and effective vaccines to improve health and save lives.
“We are honored to receive one of the top honors at this year’s ViE Awards as we remain committed to advancing our customers’ vaccine development programs to make a positive impact on the health of people across the globe,” said Jason Berg, vice president, vaccines and GPHS therapeutic head, clinical research, Thermo Fisher Scientific. “Industry awards, such as the ViE Awards, reflect our success in driving innovation and talent recruitment, further enabling us to accelerate and expedite vaccine development timelines to better serve our customers.”
With more than 30 years of commercial and government vaccine experience, the PPD clinical research business has conducted vaccine studies in more than 90 countries and works with customers across a wide spectrum of vaccine programs, from legacy vaccines to emerging pathogens. The business provides end-to-end clinical development services, including a dedicated vaccines delivery unit and vaccine-sciences, bioanalytical and central laboratories enabling customers to accelerate vaccine development timelines. The vaccine sciences lab is fully integrated with bioanalytical, central and GMP labs and clinical teams.
Thermo Fisher’s connected capabilities include a streamlined clinical research, drug development and manufacturing organization solution, combining the expertise and technology of a clinical research organization (CRO) and a contract development and manufacturing organization (CDMO). Accelerator™ Drug Development 360º CDMO and CRO solutions offer an end-to-end suite of drug development and clinical services spanning drug substance and drug product manufacturing for small molecule, large molecule, and advanced therapies, clinical supply, clinical research, and commercialization.
The ViE Awards is held during the annual World Vaccine Congress, an event comprised of a series of conferences and exhibitions focused on bringing together the most senior and informed industry experts within the vaccine industry.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.
Media Contact Information:
Nadine Maeser
Clinical Research, Thermo Fisher Scientific
Nadine.maeser@thermofisher.com